Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arizona Pharmaceuticals is a specialty pharmaceutical company based in Scottsdale, Arizona, primarily focused on the commercialization of dermatological and aesthetic products. The company holds the exclusive U.S. rights to Pliaglis, an FDA-approved topical anesthetic cream containing a combination of lidocaine and tetracaine. This product is specifically designed to provide local analgesia for patients undergoing superficial dermatological procedures such as dermal filler injections and laser treatments. Arizona Pharmaceuticals leverages a targeted sales and marketing approach to serve the medical aesthetics market. By providing effective pain management solutions, the company aims to improve the patient experience and procedural outcomes in clinical settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arizona Pharmaceuticals.